Alpha Cognition Inc.
from OTCQB Podcast Hosted by OTC Markets Group
Alpha Cognition Inc. (OTCQB: ACOGF) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and ALS. CEO Michael McFadden joins us to break down the types of neurodegenerative diseases that are targeted in the company's programs. View Podcast Transcript for Alpha Cognition
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 8 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on February 15, 2022.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.